Ibrutinib

Category: Cancer



Ibrutinib Overview

Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells. It is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia. In January 2016 ibrutinib cost US$116,600 to $155,400 a year wholesale in the United States.[1] Contents 1 Medical uses 1.1 Resistance 2 Adverse effects 3 Pharmacology 3.1 Mechanism 4 History...

Read more Ibrutinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ibrutinib

Recent Ibrutinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ibrutinib
  • Capsule: 140 Mg., 140mg, 70mg
  • Tablet: 140mg, 280mg, 420mg, 560mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ibrutinib or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA